Vfend 40 mg/ml, Pulver zur Herstellung einer Suspension zum Einnehmen - 70 ml Swissmedic Key 56819002 Registration Holder Pfizer AG Name Vfend 40 mg/ml, Pulver zur Herstellung einer Suspension zum Einnehmen Date of registration 25.11.2004 Original/Generic Original Introduction of Sequence 25.11.2004 ATC-Classification Voriconazole (J02AC03) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.06. Show package size 70 ml Index Therapeuticus (Swissmedic) 08.06. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 624.51 Limitation No Deductible 10 % Consumer price 691.75 Feedback FB Daily cost GTIN 7680568190028 Medication Code Synthetika Pharmacode 2916074 Disponibility
Composition voriconazolum 40 mg, saccharum 542.4 mg, silica colloidalis anhydrica, titanii dioxidum, xanthani gummi, natrii citras dihydricus, acidum citricum, aromatica, E 211 2.4 mg, ad pulverem corresp., suspensio reconstituta 1 ml corresp. natrium 1.08 mg. Packungsbestandteile Galenic Form Soluble Powder Excipiens Active Agent Dose Voriconazole 40 mg
BAG: Active Agent Dose Voriconazole 40 mg
Inactive agents Dose additional_information Citric Acid Aromatica E 211 2.4 mg conserv. Natrii Citras Dihydricus Saccharum 542.4 mg Silica Colloidalis Anhydrica Titanium Dioxide Xanthani Gummi
Source Data was imported : 03.02.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
